
NSF Org: |
TI Translational Impacts |
Recipient: |
|
Initial Amendment Date: | March 31, 2021 |
Latest Amendment Date: | May 21, 2021 |
Award Number: | 2120154 |
Award Instrument: | Standard Grant |
Program Manager: |
Ruth Shuman
rshuman@nsf.gov (703)292-2160 TI Translational Impacts TIP Directorate for Technology, Innovation, and Partnerships |
Start Date: | March 15, 2021 |
End Date: | June 30, 2022 (Estimated) |
Total Intended Award Amount: | $50,000.00 |
Total Awarded Amount to Date: | $50,000.00 |
Funds Obligated to Date: |
|
History of Investigator: |
|
Recipient Sponsored Research Office: |
110 21ST AVE S NASHVILLE TN US 37203-2416 (615)322-2631 |
Sponsor Congressional District: |
|
Primary Place of Performance: |
2301 Vanderbilt Place Nashville TN US 37235-0002 |
Primary Place of
Performance Congressional District: |
|
Unique Entity Identifier (UEI): |
|
Parent UEI: |
|
NSF Program(s): | I-Corps |
Primary Program Source: |
|
Program Reference Code(s): |
|
Program Element Code(s): |
|
Award Agency Code: | 4900 |
Fund Agency Code: | 4900 |
Assistance Listing Number(s): | 47.084 |
ABSTRACT
The broader impact/commercial potential of this I-Corps project is the development of a rapidly customizable, 3D printed, powered hand orthosis to help stroke survivors regain their manual dexterity and independence. Stroke is a debilitating, life-changing event. Part of the brain dies, and the mind-body connection is lost. Stroke survivors experience problems such as lack of hand control, including difficulties grasping and opening, and instability. These problems leave them dependent on others for some of the most basic tasks. Current medical devices are inadequate. The devices come in limited sizes and either prevent motion or constrain the hand to unnatural movement. A custom-sized orthosis could mitigate all these problems, providing a better fit and more effective recovery. Automating the customization process may reduce the risk of design/fitting/fabrication error by the orthotist, as well as the need for a skilled technician, in addition to time and monetary costs. The proposed technology may benefit the orthotics industry, making custom assistive devices more accessible to patients and enabling them to reach new levels of independence.
This I-Corps project is based on the development of a rapidly customizable, 3D printed, powered hand orthosis. Prior to design, anatomical data was analyzed to determine mathematical relationships between hand length and width and individual joint and bone positions. The intellectual merit of this innovation involves several key components including a smart computer aided design (CAD) package based on the anatomical relationships to generate custom size part files that can be rapidly 3D printed, reducing the need for a skilled orthosis technician. In addition, flexible joints will enable multiaxial mobility. An active, intelligent control will provide the needed assistance for users to perform activities of daily living independently. Currently, a preliminary CAD package and orthosis prototype have been developed. The primary design challenge remaining is how to fit the entire actuation system within the anthropometric envelope without sacrificing assistive capabilities.
This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
PROJECT OUTCOMES REPORT
Disclaimer
This Project Outcomes Report for the General Public is displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed in this Report are those of the PI and do not necessarily reflect the views of the National Science Foundation; NSF has not approved or endorsed its content.
Our team is developing a powered hand orthosis to help stroke survivors regain their manual dexterity and independence. It features a soft, flexible shell, rapid manufacturing through 3D printing, and active, intelligent control to help the user perform daily activities independently. This solution was developed within the structure of the NSF I-CORPS program, an intensive 7 week course emphasizing customer discovery for hypothesis testing and validating customer segments. The team conducted 145 interviews (55 via phone, 78 via video call, and 12 in person) to various customer segments related to the project. These include neurologically impaired patients (stroke, Parkinson’s disease, multiple sclerosis, and ALS), caregivers, and medical providers (doctors, nurses, and therapists). The team tested several hypotheses regarding the upper-limb struggles of neurologically impaired patients, and made several discoveries that informed the direction of the project. These include a change in device structure from rigid to flexible, a change in functional focus from fine to gross motor skills, and expanding the customer segment to include ALS as a potential target market in addition to stroke. This very valuable experience taught the team the importance of customer discovery and value propositions, developing solutions to meet the practical needs of real people, and the structure and initial financial considerations of startup businesses. After the 7 week course, our team developed a prototype and obtained IRB approval for human subjects testing.
Stroke affects millions of people across the globe every year, particularly the elderly. In the US alone, nearly 800,000 victims suffer strokes annually, and approximately 228,000 survivors end up with mild to severe upper limb impairment.
Having a stroke is a debilitating, life-changing event. Part of the brain dies, and the mind-body connection is lost. To better understand this problem, the team interviewed stroke survivors and medical providers. They emphasized lack of hand control, including difficulties grasping and opening, and instability. This leaves the survivor dependent on others for even the most basic tasks. And current medical devices are inadequate. They come in limited sizes and either prevent motion or constrain the hand to unnatural movement. Further problems emphasized by users include abrasion, discomfort, expense, and difficulty to don. The customer discovery conducted revealed many valuable insights; most significantly, that most stroke survivors need assistance with gross motor movements and would prefer a soft device to a rigidly articulated one. A customized, 3D printed soft orthosis could mitigate these problems, providing a better fit and more effective recovery. Guided by the input and experiences of stroke survivors, caregivers, and medical providers, the team developed a set of design requirements for the orthosis: easy to don, therapeutic, power assistive, intelligent, flexible, portable, and affordable.
Over the life cycle of the project so far, the team has completed:
1) Modeling the orthosis structurally in CAD
The orthosis is composed of 3D printed, opposing soft actuators, one for flexion (closing) and one for extension (opening) of the hand. An intended feature of the CAD designs is that they will be easily customizable based on previously determined mathematical parameters for various hand length and widths in order to fit a larger range of the population. At this point, both actuator designs (flexion and extension) are complete for a testable prototype.
2) 3D printing major components and assembling a prototype
Designs for the modeled actuators have been 3D printed and internal air pressure applied to view the flexion/extension behavior and experimentally determine the optimal materials, profiles, thicknesses, and internal structures of the actuators. The material of choice is TPU, a flexible thermoplastic polyurethane, which will improve comfort and reduce abrasion relative to other more rigid materials.
3) Testing the prototype to verify appropriate function
Preliminary testing of the 3D printed soft actuators has been completed as a benchtop setup. The flexion actuator curls the fingers to grasp in response to internal air pressure, while the extension actuator straightens them to open the hand. These functions can be seen in the photos included. As the actuators are iterated to optimize performance, more testing will follow.
4) Obtaining approval for human subject testing.
The team has applied to the Internal Review Board (IRB) for human subject testing, and our protocol has been approved. We look forward to this phase that will carry on to the future and provide valuable data for the benefits and improvements of this device to the stroke survivor population.
This next phase of human subjects testing could help prevent or reduce hand spasticity for neurologically impaired patients, enable them to regain or maintain their independence, and reduce hands-on time for caregivers and therapists.
Last Modified: 09/06/2022
Modified by: Eric J Barth
Please report errors in award information by writing to: awardsearch@nsf.gov.